Pacific Point Advisors’s Transmedics TMDX Stock Holding History

Pacific Point Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,000	Closed	-$561K	–	127
2024 Q4	$561K	Buy	+9,000	New	+$838K	0.34%	69

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacific Point Advisors's TMDX Position: Q1 2025 in Review

Pacific Point Advisors sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 9,000 shares — an estimated $561K sold.

Pacific Point Advisors first reported a position in TMDX in Q4 2024 and held it in 1 quarter. The position peaked at $561K in Q4 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

Pacific Point Advisors reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
Pacific Point Advisors sold 9,000 Transmedics shares in Q1 2025, an estimated $561K.
Pacific Point Advisors first reported a position in Transmedics in Q4 2024 and held it in 1 quarter.
Pacific Point Advisors's Transmedics position peaked at $561K in Q4 2024.
298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Pacific Point Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.